AKT1 and gastrointestinal stromal tumor: In addition, Zhao et al. discovered that inhibiting PD-1/PD-L1 prevents the death of CD8+ T cells in gastrointestinal stromal tumors (GIST) by modulating the AKT/PI3K/mTOR pathway.